Trial intelligence / Profile preview

Topical Ketorolac in Diabetic Macular Edema

IRCT20180819040829N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of ketorolac in diabetic macular edema (DME), sponsored by Shahid Beheshti University of Medical Sciences. Started Mar 2019; status: completed.

02

Drugs

ketorolac
03

Conditions

diabetic macular edema (DME)

Beyond the preview

Go deeper on IRCT20180819040829N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180819040829N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call